Table 4.
Medication | PAH–No CV (n = 43) | PAH-CV (n = 75) | P value |
---|---|---|---|
Phosphodiesterase 5 inhibitors | 36 (84) | 62 (83) | 0.356 |
Endothelin receptor antagonists | 21 (49) | 39 (52) | 0.289 |
Prostacyclin analogues | 6 (14) | 14 (19) | 0.125 |
Combination therapy | 19 (44) | 38 (51) | 0.176 |
Data are no. (%). CV: cardiovascular risk factors.